Literature DB >> 16822819

A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma.

Frank Weber1, Rosemary E Teresi, Christoph E Broelsch, Andrea Frilling, Charis Eng.   

Abstract

CONTEXT: Although the pathogenesis of follicular thyroid carcinoma (FTC) and its relation to follicular adenoma (FA) remains unclear, detailed understanding of FTC carcinogenesis would facilitate addressing the scientific and clinical challenges, given that there are morphological and molecular similarities between FTC and the frequently occurring FA. Micro-RNAs (miRNAs) are a new class of small, noncoding RNAs implicated in development and cancer and may lend novel clues to FTC genesis. For the latter process, a deregulated miRNA can orchestrate the aberrant expression of several hundred target genes.
OBJECTIVE: The objective of the study was to identify deregulated miRNAs in FTC.
DESIGN: We used two high-density expression arrays to identify miRNAs and their target genes that are differentially expressed between FTC and FA. Validation was done by quantitative RT-PCR. We further functionally characterized the effect of deregulated miRNAs in vitro using HEK293T, FTC133, and K5 cell lines. PATIENTS: In total, 45 primary thyroid samples (23 FTC, 20 FA, four normal control thyroid) were analyzed.
RESULTS: Two specific miRNAs, miR-197 and miR-346, were significantly overexpressed in FTC. In vitro overexpression of either miRNA induced proliferation, whereas inhibition led to growth arrest. Overexpression of miR-197 and miR-346 repressed the expression of their predicted target genes in vitro and in vivo.
CONCLUSIONS: Our observations show that miR-197 and miR-346 contribute to FTC carcinogenesis. Both miRNAs and their target genes might potentially provide for novel molecular markers and act as novel targets for treatment by interference, which could potentially normalize the deregulated profile of many downstream target genes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16822819     DOI: 10.1210/jc.2006-0693

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  94 in total

1.  Identification of microRNAs that mediate thyroid cell growth induced by TSH.

Authors:  Takeshi Akama; Mariko Sue; Akira Kawashima; Huhehasi Wu; Kazunari Tanigawa; Sayuri Suzuki; Moyuru Hayashi; Aya Yoshihara; Yuko Ishido; Norihisa Ishii; Koichi Suzuki
Journal:  Mol Endocrinol       Date:  2012-02-02

2.  Evaluation of candidate diagnostic microRNAs in thyroid fine-needle aspiration biopsy samples.

Authors:  Mio Kitano; Reza Rahbari; Erin E Patterson; Seth M Steinberg; Nijaguna B Prasad; Yongchun Wang; Martha A Zeiger; Electron Kebebew
Journal:  Thyroid       Date:  2012-02-03       Impact factor: 6.568

3.  MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer.

Authors:  Menno R Vriens; Julie Weng; Insoo Suh; Nhung Huynh; Marlon A Guerrero; Wen T Shen; Quan-Yang Duh; Orlo H Clark; Electron Kebebew
Journal:  Cancer       Date:  2011-10-17       Impact factor: 6.860

4.  The unfolded protein response (UPR)-activated transcription factor X-box-binding protein 1 (XBP1) induces microRNA-346 expression that targets the human antigen peptide transporter 1 (TAP1) mRNA and governs immune regulatory genes.

Authors:  Rafal Bartoszewski; Joseph W Brewer; Andras Rab; David K Crossman; Sylwia Bartoszewska; Niren Kapoor; Cathy Fuller; James F Collawn; Zsuzsa Bebok
Journal:  J Biol Chem       Date:  2011-10-14       Impact factor: 5.157

5.  A simple array platform for microRNA analysis and its application in mouse tissues.

Authors:  Xiaoqing Tang; Jozsef Gal; Xun Zhuang; Wangxia Wang; Haining Zhu; Guiliang Tang
Journal:  RNA       Date:  2007-08-03       Impact factor: 4.942

Review 6.  Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications.

Authors:  George A Calin; Carlo M Croce
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

Review 7.  MicroRNA expression profiles in thyroid tumors.

Authors:  Marina N Nikiforova; Simon I Chiosea; Yuri E Nikiforov
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

8.  The emergent role of microRNAs in molecular diagnostics of cancer.

Authors:  Wayne Tam
Journal:  J Mol Diagn       Date:  2008-08-07       Impact factor: 5.568

Review 9.  MicroRNAs in cancer.

Authors:  Yong Sun Lee; Anindya Dutta
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

10.  Expression and clinicopathological role of miR146a in thyroid follicular carcinoma.

Authors:  Elisa Pignatti; Eleonora Vighi; Elisa Magnani; Elda Kara; Luca Roncati; Antonino Maiorana; Daniele Santi; Bruno Madeo; Katia Cioni; Cesare Carani; Vincenzo Rochira; Manuela Simoni; Giulia Brigante
Journal:  Endocrine       Date:  2019-01-30       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.